行情

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

实时行情 | 由晨星基金提供

51.87
-0.62
-1.18%
已收盘, 16:00 06/22 EDT
开盘
52.42
昨收
52.49
最高
52.63
最低
51.49
成交量
4.55万
成交额
--
52周最高
56.32
52周最低
41.90
总资产
2.60亿
今年以来回报
-4.44%
分时
5日
1月
3月
1年
5年
3支可能反弹的医药ETF
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level. At support levels, there is more demand for the stock than there is...
Benzinga · 04/15 21:28
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
The pharmaceutical industry has delivered a C$1 billion ($761 million) proposal to the Canadian government in an attempt to stave off an upcoming price crackdown, Reuters reported 
Benzinga · 2020/11/15 16:19
特朗普签署一系列旨在降低毒品成本的行政命令
The orders, which are subject to regulatory review, are designed to bring U.S. drug prices at least on par with their costs overseas.
CNBC.com · 2020/08/06 17:46
Trump signs series of executive orders aimed at lowering drug costs
The orders, which are subject to regulatory review, are designed to bring U.S. drug prices at least on par with their costs overseas.
CNBC.com · 2020/07/24 19:53
远程医疗将为患者“成为默认值”:Ro CEO
Telehealth companies enabling individuals to see physicians without stepping foot into a physical doctor’s office are having their moment, as the coronavirus pandemic confines individuals and would-be patients across the country largely to their homes.
Yahoo Finance · 2020/05/22 12:46
在行业争夺冠状病毒治疗或疫苗的竞争中,购买合适的医疗保健ETF
John Davi, founder and chief investment officer of Astoria Portfolio Advisors, lays out some options and the risks.
CNBC.com · 2020/05/11 18:42
在经纪人会议上发表评论后,本周Mallinckrodt的股票大幅上涨,涨幅接近40%
Shares of Mallinckrodt PLC undefined shot up 22% in afternoon trading Wednesday, enough to pace the NYSE's gainers, to stretch its gains for the week to 38%....
MarketWatch · 2020/01/15 18:55
在经纪人会议上发表评论后,Mallinckrodt的股票本周大涨,接近40%的涨幅
MarketWatch · 2020/01/15 18:55
更多
暂无数据
了解XPH最新的财务预测,通过XPH每股收益,每股净资产,每股现金流等数据分析SPDR® S&P Pharmaceuticals ETF近期的经营情况,然后做出明智的投资选择。
暂无数据
评级
评级时间
评级周期
评级机构
评级
2020/08/31
3 年
晨星评级
2020/08/31
5 年
晨星评级
2020/08/31
10 年
晨星评级
  • 业绩
  • 资产分布
  • 分红历史
时间周期
回报率
同类排名
最近一天
-2.1617%
--
近一周
0.0432%
--
近一月
-0.3793%
--
近三月
0.4992%
--
近六月
5.0086%
--
今年以来
-4.4365%
--
近一年
25.1785%
--
近三年
1.2186%
--
近五年
-3.5232%
--
近十年
9.8792%
--
成立以来
9.4359%
--
暂无数据
暂无数据
  • 全部
暂无数据
简况
基金名称
SPDR® S&P Pharmaceuticals ETF
风险
中高风险
成立日期
2006-06-19
业绩比较基准
Dow Jones US Healthcare TR
管理人
State Street Global Advisors Ltd
托管人
State Street Bank & Trust Co
基金经理
Feehily/Schneider/Richardson